Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
06/2000
06/02/2000WO2000031033A1 Piperidine ccr-3 receptor antagonists
06/02/2000WO2000030638A1 Drugs and reagents containing n-acyloxylated cycloalkyl compounds as the active ingredient
06/02/2000CA2351631A1 Piperidine quaternary salts-ccr-3 receptor antagonists
05/2000
05/31/2000EP1004581A2 Process for the preparation of thalidomide
05/31/2000EP1004580A2 Imides as inhibitors of TNF alpha
05/31/2000EP1004572A2 Amines as inhibitors of TNF alpha
05/31/2000EP1004564A1 Process for the preparation of hydroxyethylcyclohexanes and hydroxyethylpiperidines
05/31/2000EP1003743A1 3,3-disubstituted piperidines as modulators of chemokine receptor activity
05/31/2000EP1003720A1 Aryloxyarylsulfonylamino hydroxamic acid derivatives
05/31/2000EP1003541A1 Inhibitors of hiv reverse transcriptase
05/31/2000EP1003540A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
05/31/2000EP1003514A1 Cyclic amine modulators of chemokine receptor activity
05/31/2000EP1003513A1 Medicinal product and method for treatment and prevention of cognitive disorders
05/31/2000EP1003511A1 ALPHA 1aADRENERGIC RECEPTOR ANTAGONISTS
05/31/2000EP0868181B1 Use of alpha,alpha-diphenylacetic acid-4-(n-methyl-piperidyl)ester as anti-spasmodic
05/31/2000DE19955340A1 CCR-3-Rezeptor-Antagonisten CCR-3 receptor antagonists
05/31/2000CN1255122A Process for preparation of 1-alkyl-3-methylpiperidone-2 and 1-alkyl-5-methylpiperidone-2
05/31/2000CN1255119A Protease inhibitors
05/31/2000CN1254596A Process for preparing composition to kill internal parasites
05/30/2000US6069254 Carboxamide derivatives of piperidine for the treatment of thrombosis disorders
05/30/2000US6069154 In humans; side effect reduction
05/30/2000US6069143 Anticoagulants
05/25/2000WO2000029377A1 4-aroyl-piperidin-ccr-3 receptor antagonists iii
05/25/2000WO2000018361A3 Method of treating hair loss using sulfonamides
05/25/2000DE19955793A1 CCR-3-Rezeptor-Antagonisten CCR-3 receptor antagonists
05/25/2000DE19853858A1 Verfahren zur Herstellung von Hydroxyethylcyclohexanen und Hydroxyethylpiperidinen A process for preparing Hydroxyethylcyclohexanen and Hydroxyethylpiperidinen
05/25/2000CA2350722A1 4-aroyl-piperidin-ccr-3 receptor antagonists iii
05/24/2000EP1002794A1 4-[(Aryl)(aryloxy)methyl]piperidine derivatives and their use as serotonin and/or noradrenaline reuptake inhibitors
05/24/2000EP1001930A2 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
05/24/2000EP1001777A1 Fibrinogen receptor antagonists
05/24/2000EP1001772A1 Improved delivery of multiple doses of medications
05/24/2000EP1001771A1 A medicament against infertility and for increasing fertility
05/24/2000EP1001766A1 Compounds and methods
05/24/2000CN1254337A N-hydroxy 4-sulfonyl butyramide compounds
05/23/2000US6066756 Phenylacetic acid derivatives, preparation thereof and intermediates therefor, and compositions containing them
05/23/2000US6066737 Process for the preparation of optically enriched 4-aryl-3-hydromethyl substituted piperidines to be used as intermediates in the synthesis of paroxetine
05/23/2000US6066666 Anticonvulsant and anxiolytic lactam and thiolactam derivatives
05/23/2000US6066656 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same
05/23/2000US6066655 For the treatment of central nervous system disorders, in particular as cerebral therapeutics
05/23/2000US6066654 Methods for treating disorders associated with the central nervous system using optically pure (-) cisapride
05/23/2000US6066651 Antithrombotic agents by virtue of their ability to prevent platelet aggregation
05/23/2000US6066650 Inhibitors of microsomal triglyceride transfer protein and method
05/23/2000US6066642 For selectively blocking the a3 adenosine receptor of a mammal
05/23/2000US6066636 Muscarinic antagonists
05/23/2000US6066632 Heterocyclic compounds
05/23/2000US6066490 Microorganisms that produces a hydrolase enzyme that demonstrates preferential activity
05/23/2000CA2181089C Piperidine derivatives and process for their production
05/23/2000CA2171637C Substituted azaheterocyclecarboxylic acids
05/23/2000CA2010578C Piperidine compounds and their preparation and use
05/18/2000WO2000027820A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors
05/18/2000WO2000027815A2 N-substituted azacycles, their preparation and their use as orl-1 receptor ligands
05/18/2000WO2000027812A1 Phenyl-substituted cyclic enaminones
05/18/2000WO2000027795A1 Transfection reagents
05/18/2000WO2000009479A3 Heterocyclic thioesters or ketones for vision and memory disorders
05/18/2000DE19851986A1 Phenyl-substituierte zyklische Enaminone Phenyl-substituted cyclic enaminones
05/18/2000CA2350305A1 Phenyl-substituted cyclic enaminones
05/18/2000CA2346898A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors
05/17/2000EP1000085A1 Treatment of insulin resistance with growth hormone secretagogues
05/17/2000EP1000048A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
05/17/2000EP1000032A1 Inhibition of pulp and paper yellowing using nitroxides and other coadditives
05/17/2000EP1000030A1 Piperidine oligomers and combinatorial libraries thereof
05/17/2000EP1000029A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders
05/17/2000EP1000028A1 Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
05/17/2000EP1000023A2 Novel nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same
05/17/2000EP0912090A4 Insecticidal n-(substituted arylmethyl)-4- bis(substituted aryl) hydroxymethyl]piperidinium salts
05/17/2000EP0770066B1 Serotonin 5-ht 1a and dopamin d2 receptor ligands
05/17/2000EP0726768B1 Use of nitric oxide releasing compounds for the manufacture of a medicament for protection in ischemia reperfusion injury
05/17/2000CN1253559A Sulfonyl divalent aryl alpha-hydroxamic acid compounds
05/17/2000CN1253547A 1,4-substituted cyclic amine derivatives
05/17/2000CN1253474A Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
05/17/2000CN1253019A Method for preparing medicine composition capable of inhibiting post infective virus proteinase
05/16/2000US6063926 Having greater bioactivity
05/16/2000US6063816 Hydroxamic acid compounds
05/16/2000US6063793 Antiserotonin agents, psychological disorders and treatment of schizophrenia
05/16/2000CA2176971C Preparation of cisapride
05/11/2000WO2000026332A1 Washing and cleaning method
05/11/2000WO2000026189A1 Method for producing nitroxyl compounds of secondary amines
05/11/2000WO2000026188A1 Cycloheximide derivatives which influence the regeneration of neural tissue
05/11/2000WO2000026187A1 Process for producing 4-arylpiperidine-3-carbinols and related compounds
05/11/2000WO2000025786A1 Heterocyclic potassium channel inhibitors
05/11/2000WO2000025782A1 Dihydropyridinones and pyrrolinones useful as alpha 1a adrenoceptor antagonists
05/11/2000WO2000025776A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
05/11/2000WO2000009110A3 N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders
05/11/2000CA2348555A1 Washing and cleaning method
05/10/2000EP0999220A2 Low molecular weight peptidomimetic growth hormone secretagogues
05/10/2000EP0998469A1 Benzamide cycloalkyl stimulating high and low gastrointestinal motricity
05/10/2000EP0998458A1 Novel benzamide derivatives stimulating high and low gastrointestinal motricity
05/10/2000EP0998451A1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use
05/10/2000EP0998286A2 Use of levobupivacaine
05/10/2000EP0743939B1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
05/10/2000EP0685234B1 Drug composition containing nucleic acid copolymer
05/10/2000CN1252803A Herbicidal sulfonamides
05/10/2000CN1252790A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
05/10/2000CN1252713A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
05/10/2000CN1052240C Method for preparing inhibitor of retroinfection viral protease
05/10/2000CN1052224C Piperidine derivatives, peripheral vasodilating agent containing it, and its use
05/09/2000US6060513 Compounds and compositions for delivering active agents
05/09/2000US6060485 Arylacetic amide derivative or salt thereof, and pharmaceutical comprising it
05/09/2000US6060476 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
05/09/2000CA2084412C Pyrrolidine and thiazolidine amides